Lupin Q1 PAT may dip 73.3% YoY to Rs 144.7 cr: ICICI Direct

ICICI Direct has come out with its first quarter (April-June’ 22) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Lupin to report net profit at Rs 144.7 crore down 73.3% year-on-year (down 127.6% quarter-on-quarter).

Net Sales are expected to decrease by 6.2 percent Y-o-Y (up 3.2 percent Q-o-Q) to Rs 4,007.1 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 50.5 percent Y-o-Y (up 102.6 percent Q-o-Q) to Rs 458.9 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.